{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:36:19Z","timestamp":1787960179843,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaut.2019.102330","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T23:51:03Z","timestamp":1567468263000},"page":"102330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study"],"prefix":"10.1016","volume":"106","author":[{"given":"Giacomo","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Campochiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Sartorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Peretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Candela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Thiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Della Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2019.102330_bib1","article-title":"Report of the 1995 world health organization\/international society and federation of cardiology task force on the definition and classification of cardiomyopathies","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2019.102330_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2011.10.001","article-title":"2011 Consensus statement on endomyocardial biopsy from the association for european cardiovascular pathology and the society for cardiovascular pathology","author":"Leone","year":"2012","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.jaut.2019.102330_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2011.09.074","article-title":"Update on myocarditis","author":"Kindermann","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2019.102330_bib4","first-page":"3","article-title":"A histopathologic definition and classification","volume":"1","author":"Myocarditis","year":"1987","journal-title":"Am. J. Cardiovasc. Pathol."},{"key":"10.1016\/j.jaut.2019.102330_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-012-9355-6","article-title":"Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial disease","author":"Basso","year":"2013","journal-title":"Heart Fail. Rev."},{"issue":"8","key":"10.1016\/j.jaut.2019.102330_bib6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.autrev.2017.05.021","article-title":"Myocarditis in auto-immune or auto-inflammatory diseases","volume":"16","author":"Comarmond","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"6","key":"10.1016\/j.jaut.2019.102330_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10741-012-9364-5","article-title":"Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management","volume":"18","author":"Caforio","year":"2013","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.jaut.2019.102330_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jtbi.2014.11.022","article-title":"Unresolved issues in theories of autoimmune disease using myocarditis as a framework","volume":"375","author":"Root-Bernstein","year":"2015","journal-title":"J. Theor. Biol."},{"issue":"11","key":"10.1016\/j.jaut.2019.102330_bib9","first-page":"1601","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.jaut.2019.102330_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.jaut.2019.102330_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehp249","article-title":"Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study","author":"Frustaci","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2019.102330_bib12","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-017-3971-4","article-title":"Lupus myocarditis receiving the rituximab therapy\u2014a monocentric retrospective study","author":"Wang","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102330_bib13","doi-asserted-by":"crossref","DOI":"10.1097\/RHU.0000000000000897","article-title":"Efficacy and safety of methotrexate for the treatment of autoimmune virus-negative myocarditis: a case series","author":"Campochiaro","year":"2018","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102330_bib14","doi-asserted-by":"crossref","DOI":"10.3109\/03009742.2016.1157626","article-title":"Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst","author":"De Luca","year":"2017","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jaut.2019.102330_bib15","first-page":"1","article-title":"Unexpected acute lymphocytic virus-negative myocarditis in a patient with limited cutaneous Systemic Sclerosis: a case report","author":"De Luca","year":"2018","journal-title":"Scand. J. Rheumatol."},{"issue":"20","key":"10.1016\/j.jaut.2019.102330_bib16","article-title":"Troponin in stable ischemic heart disease and diabetes","volume":"373","author":"Bosello","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2019.102330_bib17","article-title":"Recognizing and treating myocarditis in recent- onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression","author":"Pieroni","year":"2013","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.jaut.2019.102330_bib18","doi-asserted-by":"crossref","first-page":"e0153012","DOI":"10.1371\/journal.pone.0153012","article-title":"Prognostic role of ventricular ectopic beats in systemic sclerosis: a prospective cohort study shows ECG indexes predicting the worse outcome","volume":"11","author":"De Luca","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2019.102330_bib19","article-title":"Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: a prospective study","author":"Bosello","year":"2018","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jaut.2019.102330_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcard.2017.03.088","article-title":"QTc interval prolongation in Systemic Sclerosis: correlations with clinical variables and arrhythmic risk","volume":"239","author":"De Luca","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2019.102330_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: a JACC white paper","author":"Friedrich","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2019.102330_bib22","article-title":"Major changes made by criteria committee of the New York heart association","author":"Harvey","year":"1974","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jaut.2019.102330_bib23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","article-title":"A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis","volume":"28","author":"Caforio","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2019.102330_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2013.05.065","article-title":"Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations","author":"Ataklte","year":"2013","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.jaut.2019.102330_bib25","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1161\/CIRCULATIONAHA.106.178233","article-title":"ACC\/AHA\/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"114","author":"Zipes","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jaut.2019.102330_bib26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/heart.88.6.559","article-title":"Measuring left ventricular volume and ejection fraction with the biplane Simpson's method","volume":"88","author":"Otterstad","year":"2002","journal-title":"Heart"},{"key":"10.1016\/j.jaut.2019.102330_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ijcard.2017.11.032","article-title":"Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: an appraisal of the diagnostic strengths and limitations of the Lake Louise criteria","volume":"252","author":"Mavrogeni","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"18","key":"10.1016\/j.jaut.2019.102330_bib28","article-title":"Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis","author":"Peretto","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jaut.2019.102330_bib29","first-page":"1","article-title":"Successful use of sirolimus in a patient with cardiac microangiopathy in primary antiphospholipid syndrome","author":"Sartorelli","year":"2019","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.jaut.2019.102330_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00005-009-0013-1","article-title":"Autoimmunity and heart diseases: pathogenesis and diagnostic criteria","volume":"57","author":"Nussinovitch","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jaut.2019.102330_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2004.045518","article-title":"Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death","author":"Fabre","year":"2006","journal-title":"Heart"},{"issue":"7","key":"10.1016\/j.jaut.2019.102330_bib32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11886-017-0870-x","article-title":"Myocarditis: a clinical overview","volume":"19","author":"Caforio","year":"2017","journal-title":"Curr. Cardiol. Rep."},{"issue":"18","key":"10.1016\/j.jaut.2019.102330_bib33","first-page":"31169-X","article-title":"Arrhythmias in myocarditis: state of the art","author":"Peretto","year":"2018","journal-title":"Heart Rhythm"},{"issue":"6","key":"10.1016\/j.jaut.2019.102330_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.CIR.0000048147.15962.31","article-title":"Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders","volume":"107","author":"Frustaci","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jaut.2019.102330_bib35","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.amjcard.2008.07.041","article-title":"Giant cell myocarditis treatment trial investigators. Usefulness of immunosuppression for giant cell myocarditis","volume":"102","author":"Cooper","year":"2008","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.jaut.2019.102330_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00392-016-1011-z","article-title":"Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy","volume":"105","author":"Escher","year":"2016","journal-title":"Clin. Res. Cardiol."},{"issue":"26","key":"10.1016\/j.jaut.2019.102330_bib37","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1097\/MD.0000000000000798","article-title":"Myocarditis in patients with antisynthetase syndrome: prevalence, presentation, and outcomes","volume":"94","author":"Dieval","year":"2015","journal-title":"Medicine (Baltim.)"},{"issue":"2","key":"10.1016\/j.jaut.2019.102330_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1536\/ihj.18-299","article-title":"Intravenous immunoglobulin therapy for acute myocarditis in children and adults","volume":"60","author":"Huang","year":"2019","journal-title":"Int. Heart J."},{"issue":"6","key":"10.1016\/j.jaut.2019.102330_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","article-title":"Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases","volume":"7","author":"Nussinovitch","year":"2008","journal-title":"Autoimmun. Rev."},{"issue":"33","key":"10.1016\/j.jaut.2019.102330_bib40","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2019.102330_bib41","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3389\/fimmu.2018.01335","article-title":"Myocarditis: an interleukin-1- mediated disease?","volume":"9","author":"De Luca","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.102330_bib42","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3389\/fimmu.2018.01233","article-title":"Treating heart inflammation with interleukin-1 blockade in a case of erdheim\u2013chester disease","volume":"9","author":"Tomelleri","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2019.102330_bib43","doi-asserted-by":"crossref","DOI":"10.7326\/L18-0315","article-title":"Treatment of dilated cardiomyopathy with interleukin-1 inhibition","author":"De Luca","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.jaut.2019.102330_bib44","first-page":"253","article-title":"Advances in potential targeted therapies for Erdheim-Chester disease","volume":"5","author":"Cavalli","year":"2017","journal-title":"Expert Opin. Orphan Drugs:"},{"key":"10.1016\/j.jaut.2019.102330_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2017.00131","article-title":"Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure","volume":"8","author":"Cavalli","year":"2017","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2019.102330_bib46","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1097\/CCM.0000000000001654","article-title":"Treating life-threatening myocarditis by blocking interleukin-1","volume":"44","author":"Cavalli","year":"2016","journal-title":"Crit. Care Med."},{"issue":"24","key":"10.1016\/j.jaut.2019.102330_bib47","article-title":"Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: a case report treated with high doses (8\u200amg\/kg\/d) of anakinra","volume":"96","author":"Parisi","year":"2017","journal-title":"Medicine (Baltim.)"},{"issue":"1","key":"10.1016\/j.jaut.2019.102330_bib48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13075-019-1843-9","article-title":"Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease","volume":"21","author":"Cavalli","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2019.102330_bib49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/978-3-319-57613-8_10","article-title":"Cardiac autoimmunity: myocarditis","volume":"1003","author":"Bracamonte-Baran","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jaut.2019.102330_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"8","key":"10.1016\/j.jaut.2019.102330_bib51","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1177\/0961203318770018","article-title":"Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies","volume":"27","author":"Tanwani","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.jaut.2019.102330_bib52","article-title":"Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis","author":"Campochiaro","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.jaut.2019.102330_bib53","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Aspreva Lupus Management Study Group. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119304755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:23:29Z","timestamp":1760257409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119304755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":53,"alternative-id":["S0896841119304755"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102330","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of mycophenolate mofetil in patients with virus-negative lymphocytic myocarditis: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2019.102330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102330"}}